186 related articles for article (PubMed ID: 16078769)
1. [The threatening influenza pandemic: a national store ofoseltamivir is a waste of money].
Bonneux L
Ned Tijdschr Geneeskd; 2005 Jul; 149(29):1619. PubMed ID: 16078769
[TBL] [Abstract][Full Text] [Related]
2. [The threatening influenza pandemic: a national store of oseltamivir is necessary].
de Jong JC; Osterhaus AD
Ned Tijdschr Geneeskd; 2005 Jul; 149(29):1618. PubMed ID: 16078768
[TBL] [Abstract][Full Text] [Related]
3. Neuraminidase inhibitors and their role in avian and pandemic influenza.
Crusat M; de Jong MD
Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
[TBL] [Abstract][Full Text] [Related]
4. [Neuraminidase inhibitors in prophylaxis and treatment of influenza].
Nitsch-Osuch A; Brydak LB; Wardyn AK
Pol Merkur Lekarski; 2008 Jul; 25(145):67-73. PubMed ID: 18839619
[TBL] [Abstract][Full Text] [Related]
5. Use of antiviral agents and other measures in an influenza pandemic.
Groeneveld K; van der Noordaa J
Neth J Med; 2005 Oct; 63(9):339-43. PubMed ID: 16244380
[TBL] [Abstract][Full Text] [Related]
6. Antiviral management of seasonal and pandemic influenza.
Hayden FG; Pavia AT
J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
[TBL] [Abstract][Full Text] [Related]
7. Oseltamivir for influenza.
Drug Ther Bull; 2002 Dec; 40(12):89-91. PubMed ID: 12613182
[TBL] [Abstract][Full Text] [Related]
8. The threat of an avian influenza pandemic.
Monto AS
N Engl J Med; 2005 Jan; 352(4):323-5. PubMed ID: 15668220
[No Abstract] [Full Text] [Related]
9. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
Ward P; Small I; Smith J; Suter P; Dutkowski R
J Antimicrob Chemother; 2005 Feb; 55 Suppl 1():i5-i21. PubMed ID: 15709056
[TBL] [Abstract][Full Text] [Related]
10. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
11. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
de Jong JC; Beyer WE; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2004 Jan; 148(2):73-9. PubMed ID: 14753128
[TBL] [Abstract][Full Text] [Related]
12. Use of neuraminidase inhibitors to combat pandemic influenza.
Democratis J; Pareek M; Stephenson I
J Antimicrob Chemother; 2006 Nov; 58(5):911-5. PubMed ID: 16956904
[TBL] [Abstract][Full Text] [Related]
13. Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment.
Gillissen A; Höffken G
Med Microbiol Immunol; 2002 Dec; 191(3-4):165-8. PubMed ID: 12458353
[TBL] [Abstract][Full Text] [Related]
14. Antivirals and influenza: frequency of resistance.
Monto AS
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
[TBL] [Abstract][Full Text] [Related]
15. Experience with oseltamivir in the control of a nursing home influenza B outbreak.
Parker R; Loewen N; Skowronski D
Can Commun Dis Rep; 2001 Mar; 27(5):37-40. PubMed ID: 11260987
[TBL] [Abstract][Full Text] [Related]
16. Expanding the treatment options for influenza.
Wenzel RP
JAMA; 2000 Feb; 283(8):1057-9. PubMed ID: 10697068
[No Abstract] [Full Text] [Related]
17. [Use of Tamiflu under pandemic conditions].
Nau JY
Rev Med Suisse; 2009 Jul; 5(211):1532. PubMed ID: 19694366
[No Abstract] [Full Text] [Related]
18. Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities.
Risebrough NA; Bowles SK; Simor AE; McGeer A; Oh PI
J Am Geriatr Soc; 2005 Mar; 53(3):444-51. PubMed ID: 15743287
[TBL] [Abstract][Full Text] [Related]
19. Oseltamivir in the management of influenza.
Oxford J
Expert Opin Pharmacother; 2005 Nov; 6(14):2493-500. PubMed ID: 16259580
[TBL] [Abstract][Full Text] [Related]
20. Emergence of drug-resistant influenza virus: population dynamical considerations.
Regoes RR; Bonhoeffer S
Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]